Clinical Trial Update: A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom [Phase 2]

View source ↗

Summary

A Phase 2 safety study evaluating 1-year outcomes of OTO-104 in subjects with unilateral Meniere's disease in the United Kingdom has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniere Disease

Drugs mentioned

• OTO-104

Snippet

Sponsor: Otonomy, Inc. | Conditions: Meniere's Disease | Phase 2 | Status: COMPLETED